About Dr. Reddy's Formulations Limited
Data last updated:
Dr. Reddy's Formulations Limited is a public limited company based in Hyderabad, Telangana, India, a subsidiary of Dr Reddy's Laboratories Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24299TG2021PLC149527. Its GSTIN is 37AAICD3722H1ZP (Andhra Pradesh).
The company has an authorised share capital of ₹20.05 Cr and a paid-up capital of ₹15.05 Cr. It is led by directors including Mannam Venkata Narasimham and Sanjay Sharma.
Its last annual general meeting (AGM) was held on 21 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 8 – 2 – 337 Road No. 3 Banjara Hills Beside Tv9 Office, Hyderabad, Telangana, India – 500034.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.27 Lakh, a decline of 99% compared to the previous year. For the same year it recorded a net loss of ₹11.18 Cr and EBITDA of -₹8.23 Cr.
The company has about 8 employees on its provident fund (EPFO) records.
Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
For more details, the company can be reached via its website drreddys.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered Address8 – 2 – 337 Road No. 3 Banjara Hills Beside Tv9 Office, Hyderabad, Telangana, India – 500034
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Dr. Reddy's Formulations Limited FY 2025 filings available
Dr. Reddy's Formulations Limited reported revenue of ₹5.27 Lakh (down 99% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dr. Reddy's Formulations Limited
Revenue fell 99% in the latest year. EBITDA fell 289% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Dr. Reddy's Formulations Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹8.23 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹11.18 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dr. Reddy's Formulations Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dr. Reddy's Formulations are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors and KMP of Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations Limited currently reports 3 directors and 1 key managerial person. 1 former director has served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mannam Venkata Narasimham | Director | 11 Mar 2021 | 5 Years 7 Months | Current |
| Sanjay Sharma Also directs: Sleepsanct Partners LLP | Director | 11 Mar 2021 | 5 Years 7 Months | Current |
| Jesal Agarwal Also directs: Aurigene Pharmaceutical Services Limited, Citizen's Electoral Trust, Dres Energy Private Limited and 1 more | Ceo | 01 Aug 2025 | 1 Years 2 Months | Current |
| Manivannan Ganesh | Director | 07 Jun 2024 | 2 Years 4 Months | Current |
Peer Comparison of Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations Limited is compared with the companies closest to it by revenue in the FMCG industry (Formulations, Personal Care and Skin Care). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Provido Alserve Private Limited | ₹5.34 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Indore, Madhya Pradesh, India |
| Leefino Pharmaceuticals India Private Limited | ₹5.33 Lakh (FY 2024) | •••• | •••• | •••• | Coimbatore, Tamil Nadu, India | |
| Melorganik Private Limited | ₹5.31 Lakh (FY 2024) | •••• | •••• | -80.0% | •••• | Pune, Maharashtra, India |
| Akhil Farma Limited | ₹5.29 Lakh (FY 2025) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| G.M.Remedies Private Limited | ₹5.28 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Punjab, India |
| Dr. Reddy's Formulations Limited this company | ₹5.27 Lakh (FY 2025) | •••• | •••• | -99.0% | •••• | Hyderabad, Telangana, India |
| Jaks Suppliers Private Limited | ₹5.26 Lakh (FY 2021) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Everlyse Pharmaceuticals Private Limited | ₹5.25 Lakh (FY 2024) | •••• | •••• | -11.0% | •••• | Chandigarh, India |
| Access Pharmaceuticals Private Limited | ₹5.24 Lakh (FY 2025) | •••• | •••• | -98.0% | •••• | Ahmedabad, Gujarat, India |
| Amygdala Pharmaceutical Private Limited | ₹5.21 Lakh (FY 2025) | •••• | •••• | •••• | Barabani, West Bengal, India | |
| Nisaka Innovative Private Limited | ₹5.12 Lakh (FY 2025) | •••• | •••• | •••• | Siliguri, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Dr. Reddy's Formulations by revenue in the FMCG industry (Formulations, Personal Care and Skin Care), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations Limited is audited by A Ramachandra Rao & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| A Ramachandra Rao & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Dr. Reddy's Formulations Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations Limited has 1 court case on record: 1 filed by Dr. Reddy's Formulations. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Andhra Pradesh | Writ petition | Filed by the company against State of Andhra Pradesh | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Dr. Reddy's Formulations Limited
Employment history and EPFO contributions of people linked to Dr. Reddy's Formulations.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations Limited has 6 board changes on record since 2021: 5 appointments and 1 cessation. The latest: Jesal Agarwal was appointed as CEO on 01 Aug 2025.
Credit Ratings, Litigation & Regulatory Alerts for Dr. Reddy's Formulations Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dr. Reddy's Formulations Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dr. Reddy's Formulations Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 37AAICD3722H1ZP | Andhra Pradesh | Active | 26 Apr 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dr. Reddy's Formulations Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Related news about Dr. Reddy's Formulations Limited
Frequently Asked Questions about Dr. Reddy's Formulations Limited
Dr. Reddy's Formulations is an active public limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 March 2021 (5+ years old) and is registered under CIN U24299TG2021PLC149527.
Dr. Reddy's Formulations reported revenue of ₹5.27 Lakh for FY 2025 (down 99% YoY).
Dr. Reddy's Formulations has 4 current directors and KMP:
- Mannam Venkata Narasimham - Director
- Sanjay Sharma - Director
- Manivannan Ganesh - Director
- Jesal Agarwal - Ceo
Dr. Reddy's Formulations reported a net loss of ₹11.18 Cr and EBITDA of -₹8.23 Cr for FY 2025, as per its filed financial statements.
The GSTIN of Dr. Reddy's Formulations is 37AAICD3722H1ZP, registered in Andhra Pradesh.
The CIN (Corporate Identification Number) of Dr. Reddy's Formulations is U24299TG2021PLC149527. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Reddy's Formulations has 1 court case on record: 1 filed by the company. 1 is pending.
Dr. Reddy's Formulations was incorporated on 11 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Dr. Reddy's Formulations by revenue are Provido Alserve Private Limited, Leefino Pharmaceuticals India Private Limited, Melorganik Private Limited, Akhil Farma Limited, G.M.Remedies Private Limited and 5 more, all in the FMCG industry (Formulations, Personal Care and Skin Care).
Jesal Agarwal was appointed as CEO on 01 Aug 2025. Parag Agarwal ceased to be Director on 22 Aug 2024. Manivannan Ganesh was appointed as Director on 07 Jun 2024. Dr. Reddy's Formulations has 6 board changes on record in total.
Dr. Reddy's Formulations can be reached through the website drreddys.com. Its registered office is in Hyderabad, Telangana, India.